NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Fills Integral Role for Tumor Analyses in Novel Workflow Presented at IGCS
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was featured as an integral part of an innovative new workflow for the analysis of proteins from cancer biopsy samples. The workflow was presented during a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil. According to the update, Dr. Thomas Conrads, a nationally acclaimed protein chemist and the senior director…







